NM_182925.5(FLT4):c.3220-35_3220-2del AND not provided

Germline classification:: Benign (1 submission)
Last evaluated:: Sep 11, 2018
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000963444.3

Allele description [Variation Report for NM_182925.5(FLT4):c.3220-35_3220-2del]

NM_182925.5(FLT4):c.3220-35_3220-2del

Gene:

FLT4:fms related receptor tyrosine kinase 4 [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

5q35.3

Genomic location:

Preferred name:

NM_182925.5(FLT4):c.3220-35_3220-2del

HGVS:

NC_000005.10:g.180614181_180614214del
NC_000005.10:g.180614190_180614223del
NG_011536.1:g.40411_40444del
NM_001354989.2:c.3220-35_3220-2del
NM_002020.5:c.3220-35_3220-2del
NM_182925.5:c.3220-35_3220-2delMANE SELECT
NC_000005.9:g.180041190_180041223del
NM_002020.4:c.3220-35_3220-2delTCCACCACGGGACAAGCTTCCCTCTGTCTCCCCA

Links:

dbSNP: rs753986607

NCBI 1000 Genomes Browser:

rs753986607

Molecular consequence:

NM_001354989.2:c.3220-35_3220-2del - splice acceptor variant - [Sequence Ontology: SO:0001574]
NM_002020.5:c.3220-35_3220-2del - splice acceptor variant - [Sequence Ontology: SO:0001574]
NM_182925.5:c.3220-35_3220-2del - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: CN517202

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001110600	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Benign (Sep 11, 2018)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001110600

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Benign
(Sep 11, 2018)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV001110600.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Aug 23, 2022

ClinVar

Relating variation to medicine